Global Cardiometabolic Diseases Market by 2034: Competitive Landscape and North America Regional Growth Outlook
The global cardiometabolic diseases market is witnessing strong expansion driven by the rising prevalence of cardiovascular disease, type 2 diabetes, obesity, hypertension, and related metabolic disorders. According to industry analysis, the market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in 2025, growing at a CAGR of 4% during 2026–2034 .
This growth is...
0 Comments
0 Shares
316 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt